Glucocorticoid withdrawal syndrome following surgical remission of endogenous hypercortisolism: a longitudinal observational study.
Glucocorticoid withdrawal syndrome following surgical remission of endogenous hypercortisolism: a longitudinal observational study.
复制标题
内源性皮质醇增多症手术缓解后糖皮质激素戒断综合征:一项纵向观察研究。
DOI:
10.1093/ejendo/lvad073
复制
发表时间:
2023
影响因子:
5.8
通讯作者:
Bancos,Irina
中科院分区:
文献类型:
--
作者:
Zhang,CatherineD;Li,Dingfeng;Singh,Sumitabh;Suresh,Malavika;Thangamuthu,Karthik;Nathani,Rohit;Achenbach,SaraJ;Atkinson,ElizabethJ;VanGompel,JamieJ;Young,WilliamF;Bancos,Irina
ObjectiveGlucocorticoid withdrawal syndrome (GWS) is a scarcely studied phenomenon that complicates the recovery following surgical remission of hypercortisolism. We aimed to characterize the presence and trajectory of glucocorticoid withdrawal symptoms in the postoperative period and to determine presurgical predictors of GWS severity.DesignLongitudinal observational study.MethodsGlucocorticoid withdrawal symptoms were prospectively evaluated weekly for the first 12 weeks following surgical remission of hypercortisolism. Quality of life (CushingQoL and Short-Form-36) and muscle function (hand grip strength and sit-to-stand test) were assessed at the baseline and at 12 weeks after surgery.ResultsPrevalent symptoms were myalgias and arthralgias (50%), fatigue (45%), weakness (34%), sleep disturbance (29%), and mood changes (19%). Most symptoms persisted, while myalgias, arthralgias, and weakness worsened during weeks 5-12 postoperatively. At 12 weeks after surgery, normative hand grip strength was weaker than at baseline (meanZ-score delta −0.37,P= .009), while normative sit-to-stand test performance improved (meanZ-score delta 0.50,P= .013). Short-Form-36 Physical Component Summary score worsened (mean delta −2.6,P= .015), but CushingQoL score improved (mean delta 7.8,P< .001) at 12 weeks compared to baseline. Cushing syndrome (CS) clinical severity was predictive of postoperative GWS symptomology.ConclusionGlucocorticoid withdrawal symptoms are prevalent and persistent following surgical remission of hypercortisolism with baseline CS clinical severity predictive of postoperative GWS symptom burden. Differential changes observed in muscle function and quality of life in the early postoperative period may reflect the competing influences of GWS and recovery from hypercortisolism.